New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Global Shingles Vaccine Market was valued at US$ 3.5 Bn in 2021 and is expected to reach US$ 14.1 Bn by 2032 finds Persistence Market Research in a recent ...
EMERYVILLE, Calif., Jan. 9, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative ...